Pnc Financial Services Group, Inc. Moon Lake Immunotherapeutics Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 8,500 shares of MLTX stock, worth $341,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,500
Previous 8,180
3.91%
Holding current value
$341,020
Previous $412,000
9.47%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MLTX
# of Institutions
137Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$792 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$341 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$134 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$111 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$87.7 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.48B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...